Space
PrivateA sub-scale, fraud-born SPAC orphan now run by a credible defense fixer — Vigoride 7 finally flying real payloads buys a narrative, but ~$10M of revenue against a perpetual equity-dilution engine and a $438.6M accumulated deficit makes the equity a momentum lottery ticket, not an investment. BEARISH structurally; the float is a squeeze toy, not a moat.
Research
The verdict
A sub-scale, fraud-born SPAC orphan now run by a credible defense fixer — Vigoride 7 finally flying real payloads buys a narrative, but ~$10M of revenue against a perpetual equity-dilution engine and a $438.6M accumulated deficit makes the equity a momentum lottery ticket, not an investment. BEARISH structurally; the float is a squeeze toy, not a moat.
Primary sources
Source documents — open to read in full
Momentus is a "commercial space infrastructure" company. Per its own framing, it offers (or plans to offer — the hedging is constant) five product lines:
Core technology. The MET uses water as propellant — non-toxic, easy to handle, high specific impulse — and Momentus claims TRL-9 ("hundreds of successful firings in space"). The TASSA is a deployable/retractable solar array pitched as substantially cheaper than competitors. IP estate as of 12/31/25: eight U.S. issued patents, four non-U.S. issued, one additional application family — a thin portfolio.
Customers. Government and commercial satellite operators. In practice the 2025–26 revenue is overwhelmingly U.S. government / defense-adjacent: NASA, DARPA, AFRL, the U.S. Space Force's SpaceWERX (which awarded a Direct-to-Phase-II SBIR for an RPO sensor suite), plus commercial names flying on Vigoride 7 (Orbit Fab, Portal Space Systems, CisLunar Industries, DPhi Space, Solstar). The customers.csv on disk is empty — no per-customer revenue concentration is compiled, so concentration below is inferred from disclosure.
Contract structure. Hosted-payload and engineering-services contracts, recognized over time as performance obligations are satisfied. No take-or-pay, no recurring SaaS-like base — revenue is project-lumpy (the 10x YoY Q1 swing, $0.3M → $3.2M, proves it). Backlog is not quantified anywhere in the 10-K beyond risk-factor boilerplate about "converting backlog or inbound inquiries into revenue" — a tell that backlog is immaterial or undisclosed.
Bottom line: a pre-commercial space-logistics option with one genuinely-differentiated subsystem (water-plasma propulsion), monetized today as a government hosted-payload integrator, wrapped in a much larger "someday in-orbit servicing" story.
The commercial-layer supply-chain.md for the space topic is missing (the briefing flags it), so this is mapped from the 10-K + web. Named stakeholders along the chain:
Upstream (inputs into Momentus):
Momentus (the integrator): designs/builds the Vigoride OSV and buses in San Jose (1762 Automation Parkway), integrates customer payloads, obtains FCC/export licenses, operates the vehicle on orbit.
Downstream (end customers): U.S. government (NASA, DARPA, AFRL, SpaceWERX) + commercial satellite operators / space-tech startups (Orbit Fab, Portal Space, CisLunar, DPhi, Solstar).
Chokepoints / single-source dependencies:
This lens is thin by necessity — Momentus is small enough that its "supply chain" is mostly "buy a SpaceX seat, integrate in-house, get a license."
Claimed moats: (1) modular common technology across vehicles; (2) patent-pending water-plasma propulsion; (3) launch-provider compatibility/relationships; (4) an experienced management team (ex-DoD, Raytheon, Lockheed, Maxar, ULA, Northrop).
Honest assessment — the moat is shallow-to-nonexistent at current scale:
The only real edge is credibility-as-a-defense-vendor — John Rood's national-security résumé reopened the U.S.-government door that founder Kokorich's CFIUS problem had slammed shut. That is a relationship/clearance moat, not a technology moat, and it is personal to Rood.
segments.csv is empty — Momentus does not report multiple segments. It operates as a single reportable segment reviewed by the CEO as chief operating decision-maker. All revenue is "Service revenue."
By the only available cut — period and (inferred) end-market:
| Period | Service revenue | Source |
|---|---|---|
| FY2024 | $2,114K | |
| FY2025 | $1,110K (−47% YoY) | |
| Q1 2025 | $322K | |
| Q1 2026 | $3,215K (+899% YoY) |
Trend & cause. FY2025 revenue fell 47% as the Vigoride 5/6 performance obligations wound down. Then Q1 2026 exploded to $3.2M — more than all of FY2025 in a single quarter — driven by the Vigoride 7 hosted-payload mission and government engineering-services work. Management now guides ~$10M FY2026 revenue. Geographic split is not disclosed; the de-facto concentration is U.S. government. The takeaway: revenue is mission-gated and binary — it spikes when a Vigoride flies and collapses between missions. There is no smooth segment trend to extrapolate; there is a launch calendar.
FY2025 income statement:
| Line | FY2025 | FY2024 | Δ |
|---|---|---|---|
| Service revenue | $1,110K | $2,114K | −47% |
| Cost of revenue | $2K | $66K | −97% |
| Gross profit | $1,108K | $2,048K | — |
| R&D | $9,190K | $9,782K | −6% |
| SG&A | $19,173K | $21,949K | −13% |
| Total operating expenses | $28,363K | $31,731K | −11% |
| Loss from operations | $(27,255)K | $(29,683)K | +8% (smaller loss) |
| Net loss | $(30,468)K | $(34,946)K | −13% (smaller loss) |
| Net loss attributable to common | $(30,585)K | $(34,946)K | — |
| Accumulated deficit | $(438.6)M | — | — |
Q1 2026: Service revenue $3,215K (vs $322K), cost of revenue $1,398K, R&D $4,169K, SG&A $6,340K, total opex $10,509K, loss from operations $(8,692)K, net loss $(9,480)K (vs $(6,172)K — loss widened YoY despite the revenue jump, because opex scaled with the Vigoride 7 campaign).
Read-through:
Balance sheet (12/31/25): Total assets $40.3M (up sharply from $9.95M a year earlier — financing-driven: cash + a $9.3M "prepaids/other current assets" line that includes prepaid launch/services, + $11.3M restricted cash), total liabilities $23.2M, stockholders' equity swung to +$17.1M from a $(7.8)M deficit — entirely because of equity raises, not earnings.
Cash flow: Net cash used in operating activities $(23.3)M in FY2025 (vs $(16.6)M FY2024) — burn accelerated by ~40%. Against year-end cash of $12.8M, that is roughly half a year of runway absent new financing — which is exactly why the going-concern flag was raised.
Guidance & tone change. The pivotal disclosure shift: the 10-K (March 2026) carried explicit going-concern / substantial-doubt language; the Q1 10-Q (May 2026) states "substantial doubt no longer exists" after ~$84.6M of post-year-end raises lifted cash to ~$76M. Tone flipped from survival to "executing long-term growth strategy."
Market reaction: violent. MNTS ran from a $4.57 close (May 1) to $13.85 (May 26), +200%+, on the Q1 print + going-concern removal + SpaceX-IPO-halo, then bled back toward ~$7.30 by June 29. This is squeeze-and-fade behavior, not fundamental re-rating.
transcripts/ is empty (none ingested; the small-cap calls are not on Fool/Insider-Monkey). Sentiment is reconstructed from filings + press releases, so treat the trend as ``-derived.
Trajectory of management messaging over the last ~4 quarters:
Recurring phrases: "in-space infrastructure services," "modular vehicles," "water plasma propulsion," "flight heritage," "fully subscribed." What they stopped saying: the going-concern caveat (dropped in May 2026) and the reverse-split/compliance language (resolved). The sentiment arc is genuinely improving — but it tracks the financing window and one successful deployment, not durable commercial traction. The risk is that the same arc has played before (post-2021 it was also "real technology, real customers") and ended in two reverse splits.
Momentus is nearly un-comparable on multiples — it has almost no revenue, so EV/Sales is meaningless-to-absurd and there are no earnings for P/E. Multiples below are ``; where a clean figure isn't sourceable it is marked n/a. ROE for a company with a $438.6M accumulated deficit and equity that only just turned positive is not meaningful (n/m).
| Company | Ticker | ~Mkt cap (USD) | 2026E revenue | EV/Sales | P/E | 5-yr avg ROE | Notes |
|---|---|---|---|---|---|---|---|
| Momentus | MNTS | ~$42M (June 29) | ~$10M guide | ~4x on guide / ~38x on FY25 actual | n/m (loss) | n/m | Sub-scale; squeeze-driven cap, swung $42M–$228M intra-month |
| Rocket Lab | RKLB | ~$50B+ | ~$800M+ (Q1 $200.3M, +63%) | ~73x sales | n/m | n/m | Scaled launch + space systems; the category bellwether |
| Redwire | RDW | mid-cap | $450–500M guide | ~5.7x sales | n/m | n/m | Space infrastructure/components; closest "infra" peer |
| Voyager Technologies | VOYG | $225–255M guide (FY25 $166.4M) | n/a | n/m | n/m | Defense/space, station-adjacent | |
| Astroscale | (TYO/private-ish) | n/a | n/a | n/a | n/m | n/m | Closest pure servicing/RPO peer; debris-removal leader, far better funded |
| D-Orbit | private (IT) | n/a | n/a | n/a | n/m | n/m | Real commercial last-mile heritage (ION), direct tug competitor |
| Impulse Space | private (US) | n/a | n/a | n/a | n/m | n/m | Best-funded new tug entrant (Mira/Helios) — the dangerous one |
What the table says: the credible public space-infrastructure names trade on hundreds of millions of revenue (Redwire ~5.7x sales; Rocket Lab ~73x sales on a growth premium). Momentus has ~$10M of guided revenue and a market cap that is a rounding error and a function of float-squeeze mechanics, not fundamentals. On its FY2025 actual $1.1M, the ~$42M cap is ~38x trailing sales for a shrinking, loss-making, serially-diluting micro-cap. There is no multiple at which this is "cheap"; it is an option on execution, priced by sentiment.
What has moved MNTS >5% over its public life:
Pattern: MNTS reacts to exactly two things — (1) dilution events (always down) and (2) narrative/mission/macro-halo events (sharp, short-lived squeezes up). It does not re-rate on fundamentals because there are none to anchor to. This is a catalyst-and-float trading vehicle: low share count post-split (5.7M → ~10M and climbing), high retail interest, SpaceX-IPO beta. The tape rewards momentum and punishes the inevitable next raise.
CEO / President / Chairman: John C. Rood (since Aug 2021). The defining fact about Momentus's management is that Rood was installed as the fix for the fraud. Background:
Why he matters: Rood's clearances and DoD relationships are the asset. Founder Mikhail Kokorich (Russian-born) was a CFIUS national-security problem that blocked the licenses Momentus needs; the SEC found Momentus misrepresented how badly that undermined its licensing. Rood is the American defense insider who made Momentus fundable by U.S. government customers again. CFO: Lon Ensler.
Skin in the game / insider ownership: thin. The 10-K shows the meaningful equity holders are the financing counterparties — serial warrant investors (March/Aug/Oct/Dec 2025 warrant tranches, each with 9.99% beneficial-ownership blockers) and entities like "SIV" (Space Infrastructures Ventures) — i.e. the cap table is dominated by dilutive financiers, not aligned founder/insider stakes. After two reverse splits and constant issuance, original insider stakes are heavily diluted.
Capital-allocation history: value-destructive by necessity. $438.6M of cumulative losses funded almost entirely by equity; two reverse splits; ROE/ROIC deeply negative throughout. Management's "capital allocation" is serial dilution — there is no buyback, no acquisition discipline, no FCF to allocate. To their credit, the company is now debt-free with ~$76M cash, and they have repeatedly avoided delisting and bankruptcy — survival itself is a (low-bar) achievement.
Founder vs. professional manager: decisively professional/turnaround manager (the founder was forced out). Implication: Momentus is run by a credentialed fixer optimizing for survival, government access, and narrative — appropriate for its stage, but it means the company lacks a technical founder-visionary driving the product, and the CEO's edge (DoD relationships) is personal and non-transferable.
Red flags: the entire founding fraud (Lens 10); pay-vendors/settle-disputes-in-stock behavior (e.g. issuing 5,723 shares to a vendor in March 2026 to settle payables ); a cap table built on toxic-adjacent warrant financing.
Accounting-statement risks:
Regulatory findings (required sub-section):
regulatory/regulatory-findings.md reports 0 Litigation Releases and 0 AAERs naming Momentus in 2021-06-30 → 2026-06-30. However, this understates reality: the landmark action was an administrative cease-and-desist settlement, not an LR/AAER, so it does not appear in those two indices.Momentus does not give multi-year EPS guidance; it guides only ~$10M FY2026 revenue. EPS is deeply negative and dominated by a moving, diluting share count (5.73M shares at the 10-K → ~9.99M by mid-May → climbing as the $75M ATM is used). Projecting EPS three years out for a pre-commercial serial-diluter is low-confidence by construction; I give a directional range and explicitly refuse to manufacture false precision. No forecast.ts logged (unattended --watchlist; no committed base case — this is a watch, not a conviction position).
Inputs:
Three-year EPS path:
The honest projection: there is no credible path to positive EPS within three fiscal years. The investable question is not "what's the EPS" — it's "does the cash runway (~$76M, mid-2026) reach enough revenue-generating missions to keep the equity window open without a value-destroying down-round or another reverse split?" At ~$23M/yr operating burn, $76M is ~3 years of runway if burn doesn't rise — but burn rises with mission cadence, and the $75M ATM signals management expects to keep tapping the market.
Bull case. Momentus is a cheap (~$42M) call option on three converging tailwinds: (1) a structurally growing space-logistics/in-orbit-servicing market (autonomous space-tug market ~$1.8B in 2026 → ~$3.3B by 2030 at ~16.6% CAGR; orbital-transfer tug forecasts as high as ~$7.9B by 2033 ); (2) genuinely differentiated, flight-proven water-plasma propulsion and a credible DoD/NASA customer roster (SpaceWERX RPO award, NASA Space Act Agreement, Vigoride 8 NASA-subscribed); (3) a defense-credentialed CEO who reopened the government channel. With going-concern doubt removed, ~$76M cash, debt-free, and Vigoride 7 flying 10 real payloads, the survival overhang has lifted — and in a SpaceX-$1.75T-IPO-halo environment, a sub-scale name with real hardware and a low float can re-rate violently (it already ran +200% on the Q1 print). If the RPO/servicing demos succeed, Momentus becomes an acquisition target or a genuine niche servicing prime.
Bear case (the structural reality — 2–3 permanent-impairment risks):
Pre-mortem (18 months out, thesis broke): Vigoride 7's RPO/servicing demos disappointed or a subsequent mission failed; the SpaceX-IPO halo faded and the space-momentum trade reversed; the $75M ATM got used at progressively lower prices, the stock slid back below $1 post-dilution, and a third reverse split was announced — going-concern doubt returned. The squeeze-buyers from May 2026 were the exit liquidity.
Are multiples too high? There is no multiple — it's an option priced on sentiment. At ~38x trailing actual sales (and only ~4x on a guided number management has every incentive to hit-or-miss), it is expensive for what it is: a pre-commercial, cash-burning micro-cap. The market is pricing optionality + squeeze mechanics, not cash flows.
Contrarian view (what the market refuses to see): Bulls see "debt-free, $76M cash, going-concern removed, revenue +900%, SpaceX halo" and price a turnaround. The contrarian read: the going-concern removal is the tell, not the all-clear — it was bought with $84.6M of dilution at squeeze-inflated prices, which is precisely how this management funds a structurally-unprofitable business between narrative spikes. The +900% revenue is $0.3M → $3.2M — a single mission, not a trend. The most dangerous thing for new shareholders is that the company is now well-capitalized enough to keep diluting them for two more years without the discipline of an imminent bankruptcy.
Dismantling the bull case:
A debt-free, 59%-gross-margin device compounder mispriced as "space" — the real bet is whether the FY25–26 fitness-wearable share surge is a durable re-rating or a post-pandemic echo that decays back to mid-single-digit growth at a 24x multiple that already pays for the good case.
The only credible bet on FULL (both-stages) reuse besides SpaceX — a metallurgy/physics moat the others ducked — but it is a single-vehicle, zero-revenue, zero-flights company whose entire value is gated on one un-flown second stage surviving reentry; WATCHING, not investable, until Nova reaches orbit and the upper stage comes home intact.
A genuine launch-and-connectivity monopoly wrapped inside an unprofitable $2T+ aspiration stock — Starlink is the real business, but at ~110x sales the market is paying for Mars, orbital AI data centers, and a $60B Cursor bet that aren't earnings yet.